Jun 30, 2026 07:00AM
Jun 30, 2026 07:00AM
Apr 30, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 12, 2026 07:12AM
Feb 11, 2026 05:54PM
Feb 11, 2026 05:54PM U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
Jan 12, 2026 07:01AM
Jan 12, 2026 07:00AM
Oct 30, 2025 07:00AM
Sep 29, 2025 04:30PM
Sep 29, 2025 04:30PM
Aug 20, 2025 07:01AM
Aug 20, 2025 07:00AM Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer
Jul 24, 2025 07:00AM
Jul 1, 2025 07:00AM
May 31, 2025 03:08PM
May 31, 2025 08:00AM
Apr 25, 2025 06:54AM
Apr 24, 2025 07:00AM
Apr 22, 2025 07:12AM Novocure's (NVCR) Optune Lua Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer
Apr 22, 2025 07:09AM
Feb 27, 2025 07:00AM
Jan 13, 2025 07:06AM
Jan 13, 2025 07:00AM
Nov 21, 2024 07:01AM
Nov 21, 2024 07:00AM
Oct 30, 2024 07:00AM Novocure Reports Third Quarter 2024 Financial Results
Oct 16, 2024 06:06AM
Oct 15, 2024 04:44PM
Oct 15, 2024 04:43PM
Oct 15, 2024 04:36PM
Oct 15, 2024 04:09PM
May 3, 2024 06:48AM
May 2, 2024 04:48PM NovoCure Ltd. (NVCR) PT Lowered to $14.50 at Evercore ISI
May 2, 2024 07:00AM
Mar 27, 2024 11:47AM
Feb 22, 2024 07:00AM
Jan 18, 2024 07:00AM
Jan 18, 2024 07:00AM
Jan 8, 2024 07:00AM
Nov 10, 2023 08:00AM Novocure Announces Presentations on Tumor Treating Fields Therapy, Including New Clinical Data and Real-World Evidence, at 2023 Society for Neuro-Oncology Annual Meeting
Oct 26, 2023 07:00AM
Aug 30, 2023 05:51AM
Aug 29, 2023 06:31PM
Jul 31, 2023 08:25PM
Jul 27, 2023 07:00AM
Jul 22, 2023 09:30AM
Jul 3, 2023 09:00AM NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
Jun 29, 2023 09:00AM

324,764 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All